What Know About Orbimed's Influence on Enliven's 130% Rally
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
Find clear guidance on which blue chip coin to start with, including risk notes and a simple starter approach for newcomers.
22,235 articlesA major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
Ethereum faces renewed selling as large holders dump roughly 550,000 ETH in a week, pushing prices toward key support...
A powerful shift is forming: auto plants turning into energy storage hubs to power data centers and grids. This unsto...
Wingstop topped Q4 expectations, delivering a key earnings beat while expanding its restaurant base. The dual story: ...
JPMorgan Chase moves to a two-person succession test by naming Doug Petno and Troy Rohrbaugh co-presidents, laying th...
Founders Fund's ETHZilla fully liquidates its ether holdings, selling $74.5 million as the crypto market slides. The ...
The Supreme Court declined to hear Alan Dershowitz's $300 million defamation suit against CNN, ending a high-profile ...
Bitcoin remains range-bound under pressure around the $55,000 mark as on-chain metrics flag weak demand. Analysts say...
As U.S. AI export controls tighten, investors face a push-pull: tighter access could spur China’s open-source AI ecos...
As markets wobble in early 2026, utility ETFs provide a steady dividend stream and a shield against volatility. This ...
A Jersey Republican is set to reappear in Congress after nearly four months away, citing an unspecified medical condi...
New data shows many Americans over 50 have under 50k saved for retirement, highlighting a growing gap between savings...